InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 12 transactions totaling $127.3K, demonstrating a bullish sentiment with $127.2K in net insider flow. The most recent transaction on Jul 31, 2024 involved a sale of 240 shares valued at $43.
INM Insider Activity Summary
Who Is Buying INM Stock?
No significant insider buying has been recorded for INM in the recent period.
Who Is Selling INM Stock?
No significant insider selling has been recorded for INM in the recent period.
Is InMed Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INM is bullish with an Insider Alignment Score of 100/100 and a net flow of $127.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INM Frequently Asked Questions
Understanding INM Insider Activity
Insider trading at InMed Pharmaceuticals Inc. (INM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading INM stock, having executed 12 transactions in the past 90 days. The most active insider is Eric A. Adams (Executive), who has made 5 transactions totaling $70.0K.
Related Tools
Track InMed Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at INM file new Form 4 transactions